A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus — REEF-D

Hepatitis D, Chronic Clinical Trial

Official title:
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled Study With Deferred Active Treatment to Investigate the Efficacy, Safety, and Pharmacokinetics of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

Status Active, not recruiting

Clinical Trial Summary

The purpose of the study is to evaluate on-treatment efficacy against hepatitis D virus (HDV) of JNJ-73763989 + nucleos(t)ide analog (NA) regimen compared to NA alone.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04535544
Study type	Interventional
Source	Janssen Research & Development, LLC
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	September 17, 2020
Completion date	February 5, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05461170` - SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.	Phase 2
Completed	`NCT02732639` - A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)	Phase 3
Completed	`NCT02731131` - A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)	Phase 2
Completed	`NCT02765802` - A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection	Phase 2
Active, not recruiting	`NCT05229991` - Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection	Phase 3
Terminated	`NCT01861444` - An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)	N/A
Active, not recruiting	`NCT03105310` - Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D	Phase 2
Recruiting	`NCT04166266` - Observatory of Efficacy and Safety of Bulevirtide in Patients With Chronic HBV/HDV Co-infection
Completed	`NCT01088659` - A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.	Phase 3
Completed	`NCT00686790` - Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)	Phase 3
Completed	`NCT02876419` - A Long Term Follow-up Study of Patients From the REP 301 Protocol